Saba Capital Management, L.P. filed a Form 4 on October 28, 2026, disclosing a purchase of 300 shares of common stock in Gabelli Healthcare & WellnessRx Trust on October 27, 2026.

Key Highlights

  • Transaction: Saba Capital Management, L.P. acquired 300 shares of common stock on October 27, 2026, with transaction code P (purchase).
  • Price paid: $9.99 per share, according to the filing.
  • Post-transaction ownership: Following the reported transaction, Saba Capital Management, L.P. beneficially owned 2,174,125 shares, held indirectly.
  • Ownership basis: The securities are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager.
  • 10% Owner: Saba Capital Management, L.P. is identified in the filing as a 10% owner of the issuer.
  • Key individuals: Boaz R. Weinstein serves as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.

Saba Capital's October 27 Purchase in Gabelli Healthcare & WellnessRx Trust

According to the Form 4 filed with the SEC on October 28, 2026, Saba Capital Management, L.P. reported a purchase of 300 shares of common stock in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) at a price of $9.99 per share. The transaction was dated October 27, 2026, and carries transaction code P, indicating an open-market purchase.

The filing indicates that following this transaction, Saba Capital Management, L.P. beneficially owned a total of 2,174,125 shares of common stock, held indirectly. The filing explains that "the securities reported herein are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." Boaz R. Weinstein, identified as managing member of Saba Capital Management GP, LLC - the general partner of Saba Capital Management, L.P. - is also named in connection with the filing. The form was signed by Maria Piccolino on behalf of Saba Capital Management, L.P., and by Boaz Weinstein, both on October 28, 2026.

Saba Capital Management, L.P. is listed in the filing as a 10% owner of the issuer. No derivative securities transactions were reported in Table II of this filing.

What Was Disclosed

Saba Capital Management, L.P. disclosed an indirect purchase of 300 common shares of Gabelli Healthcare & WellnessRx Trust at $9.99 per share on October 27, 2026, bringing its total indirect beneficial ownership to 2,174,125 shares.